admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange

PTSF64 – The First Woman to Take Acid, The Drug Policy...

atai Life Sciences Announces Pricing of Upsized Initial Public Offering

Diamond Therapeutics contracts BioPharma Services for Phase 1 clinical trial

Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical...

Silo Wellness and Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Announces...

Awakn Life Sciences Corp. Announces Completion Of Reverse Takeover Transaction, Release...

MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory Board

Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year...

Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT...

1...208209210...218 Page 209 of 218

Advanced Shadow Work and Psychedelic Integration: A Jungian Path to Wholeness

Essentials of Psychedelic Therapy & Integration

Pα+ Psychedelic Bulletin #206: Q2’25 Psychedelic Lobbying; Tabernanthalog’s Neuroplasticity Pathway; UK...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin